Journal Articles

One way of disseminating information learned from projects of the Centers for Education & Research on Therapeutics (CERTs) is through publication in peer-reviewed medical journals. This section shows CERTs journal articles published from 2000 through 2006. It will be updated soon to include the most current journal articles.

2005

A-E

• Aberra FN, Brensinger CM, Bilker WB, Lichtenstein GR, Lewis JD. Antibiotic use and the risk of flare of inflammatory bowel disease. Clin Gastroenterol Hepatol 2005;3:459-465.
• Al-Khatib SM, Allen LaPointe NM, Kramer JM, Chen AY, Hammill BG, Delong L, Califf RM. A survey of health care practitioners' knowledge of the QT interval. J Gen Intern Med 2005;20:392-396.
• Aspinall SL, Berlin JA, Zhang, Y, Metlay, JP. Facility-level variation in antibiotic prescriptions for veterans with upper respiratory infections. Clin Ther 2005;27:258-262.
• Barton TD, Fishman NO, Weiner MG, LaRosa LA, Lautenbach E. High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications. Infect Control Hosp Epidemiol 2005;26:93-99.
• Cooper WO, Arbogast PG, Hickson GB,Daugherty JR, Ray WA. Gaps in enrollment from a Medicaid managed care program: effects on emergency department visits and hospitalizations for children with asthma. Medical Care 2005;43:718-725
• Cowper PA, Udayakumar K, Sketch MH Jr, Peterson ED. Economic effects of prolonged clopidogrel therapy following percutaneous coronary intervention. J Am Coll Cardiol 2005;45:369-376.
• Curtis JR, Olivieri J, Allison JJ, Gaffo A, Juarez L, Kovac SH, Person S, Saag KG. A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs Am J Manag Care 2005;11:537-543.
• Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients Arthritis Rheum 2005;52:2485-2494.

F-I

• Fessler BJ, Alarcon GS, McGwin G Jr, Roseman J, Bastian HM, Freidman AW, Baethge BA, Vila L, Reveille JD; for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups: XVI: Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 2005;52:1473-1480.
• Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case control study Lancet 2005;365:475-481.
• Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005;14:789-793.
• Halpern SD, Barton TD, Gross R, Hennessy S, Berlin JA, Strom BL. Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reported. Pharmacoepidemiol Drug Saf 2005;14:155-161.
• Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons willingness to provide organs for patients infected with HBV, HCV or HIV. Am J Transplant 2005;5:1319-1325.
• Harrold LR, Andrade SE, Go AS, Buist AS, Eisner M, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005;32:1076-1080.
• Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 2005;165:1375-1380.
• Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao, X, Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species Clin Infect Dis 2005;40:1317-1324.

J-N

• Kramer JM. Managing the risks of therapeutic products: proceedings of a workshop. Pharmacoepidemiol Drug Saf 2005;14:619-628.
• Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis 2005;41:923-929.
• Lautenbach E, Harris AD, Perencevich EN, Nachamkin I, Tolomeo P, Metlay JP. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother 2005;49:798-800.
• Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005;14:443-451.
• Levy RM, Leyden JJ, Margolis DJ. Colonisation of Streptococcus pyogenes and Staphylococcus aureus in the oropharynx of a young adult population. Clin Microbiol Infect 2005;11:153-155.
• Long CB, Shah SS, Lautenbach E, Coffin SE, Tabbutt S, Gaynor JW, Bell LM. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J 2005;24:315-319.
• Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm 2005;62:1983-1991.
• Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005;141:1132-1136.
• Mazor KM, Simon SR, Yood RA, Martinson BC, Gunter MJ, Reed GW, Gurwitz JH. Health plan members' views on forgiving medical errors. Am J Manag Care 2005;11:49-52.
• McPhillips HA, Stille CJ, Smith D, Hecht J, Pearson J, Stull J, Debellis K, Andrade S, Miller M, Kaushal R, Gurwitz J, Davis RL. Potential medication dosing errors in outpatient pediatrics. J Pediatr 2005;147:761-767.
• Mebane FE. The importance of news media in pharmaceutical risk communication: proceedings of a workshop Pharmacoepidemiol Drug Saf 2005;14:297-306.
• M'ikanatha NM, Julian KG, Kunselman AR, Aber RC, Rankin JT, Lautenbach E,. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak. BMC Public Health 2005;5:2.
• Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-272.
• Mikuls TR, Saag KG, George V, Mudano AS, Banerjee S. Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture. J Rheumatol 2005;5:870-875.
• Mikuls TR, Farrar JT, Bilker WB, Fernandez S, Saag KG. Sub-optimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricemia: results from the U.K. General Practice Research Database (GPRD) Rheumatology (Oxford) 2005;44:1038-1042.
• Mouton JW, Vinks AA. Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration. Clin Pharmacokineics 2005;44(2):201-10.

O-Z

• Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA Spontaneous Reporting System. Pharmacoepidemiol Drug Saf 2005;14:747-753.
• Pisu M, James N, Sampsel N, Saag KG. The cost of glucocorticoid-associated adverse events in rheumatoid arthritis. Rheumatology (Oxford) 2005;44:781-788.
• Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf 2005;14:829-836.
• Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith DH, Andrade SE, Soumerai SB. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care 2005;43:951-959.
• Santell JP, Hicks RW. Medication errors involving pediatric patients. Joint Commission Journal on Quality and Patient Safety 2005 Jun;31(6):348-53.
• Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in US Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc 2005;53:227-232.
• Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, Kleinman K, Miroshnik I, Soumerai SB. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med 2005;118:521-528.
• Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Annals of Pharmacotherapy, 2005; 39 1785-1791.
• Touw DJ, Neef C, Thomson AH, Vinks AA. Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology. Cost-effectiveness of Therapeutic Drug Monitoring: A Systematic Review. Therapeutic Drug Monitoring 2005;Feb;27(1):10-17.
• Viray M, Linkin D, Maslow JN, Stieritz DD, Carson LS, Bilker WB, Lautenbach E. Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol 2005;26:56-62.
• Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 2005;115:942-949.